Get started
Numinus Wellness Inc.Numinus Wellness Inc.Numinus Wellness Inc.

Numinus Wellness Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Seasonals

LR23 chart


Full chart

LR23 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.67 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0649 EUR
Net income (FY)
‪−20.65 M‬ EUR
Revenue (FY)
‪15.82 M‬ EUR
Shares float
‪309.64 M‬
Beta (1Y)
1.44

About NUMINUS WELLNESS INC


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Payton Nyquvest
Website
numinus.com
Headquarters
Vancouver
Founded
1962
FIGI
BBG001HM6B81
Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. It also provides psychedelic, therapy, neurology, wellness, clinical trials, and training services. The company was founded by Payton Nyquvest and Stacey Wallin on June 26, 1962 and is headquartered in Vancouver, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LR23 news



Ideas



See all ideas 

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Numinus Wellness Inc. stocks are traded under the ticker LR23.
LR23 reached its all-time high on Dec 15, 2020 with the price of 1.5700 EUR, and its all-time low was 0.0115 EUR and was reached on Nov 1, 2024. View more price dynamics on LR23 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Numinus Wellness Inc. financials in yearly and quarterly reports right on TradingView.
Numinus Wellness Inc. is going to release the next earnings report on Jan 20, 2025. Keep track of upcoming events with our Earnings Calendar.
LR23 earnings for the last quarter are −0.01 EUR per share, whereas the estimation was −0.01 EUR resulting in a −100.00% surprise. The estimated earnings for the next quarter are −0.01 EUR per share. See more details about Numinus Wellness Inc. earnings.
Numinus Wellness Inc. revenue for the last quarter amounts to ‪2.94 M‬ EUR, despite the estimated figure of ‪3.70 M‬ EUR. In the next quarter, revenue is expected to reach ‪3.09 M‬ EUR.
LR23 net income for the last quarter is ‪−3.89 M‬ EUR, while the quarter before that showed ‪−4.06 M‬ EUR of net income which accounts for 4.07% change. Track more Numinus Wellness Inc. financial stats to get the full picture.
No, LR23 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 200.00 employees. See our rating of the largest employees — is Numinus Wellness Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Numinus Wellness Inc. EBITDA is ‪−11.42 M‬ EUR, and current EBITDA margin is −104.07%. See more stats in Numinus Wellness Inc. financial statements.
Like other stocks, LR23 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Numinus Wellness Inc. stock right from TradingView charts — choose your broker and connect to your account.